CareDx, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results

Go back to CareDx, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results

CareDx (CNDA) PT, Estimates Cut at Piper Jaffray Post Q4

March 18, 2015 8:51 AM EDT

Piper Jaffray analyst William R. Quirk lowered estimates and his price target on CareDx, Inc (NASDAQ: CDNA) to $8.00 (from $13.00) following Q4 results but maintained an Overweight rating.

Quirk commented, "CareDx reported 4Q14 revenue growth of 35.8% to $8.0M, above our ($6.7M) and consensus ($6.9M) expectations, although a... More

CareDx (CDNA) Tops Q4 EPS by 11c

March 17, 2015 4:13 PM EDT

CareDx (NASDAQ: CDNA) reported Q4 EPS of $0.00, $0.11 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $7.96 million versus the consensus estimate of $6.86 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

... More